Table 3.

Subgroup analysis examining differential effects of P2Y12 inhibitors on the risk of major osteoporotic fractures

Subgroup	Hazard ratio	95% Confidence interval		P value for interaction
Age group				0.80
≤ 65 years	0.66	0.38	1.13
> 65 years	0.61	0.41	0.91
Sex				0.34
Male	0.53	0.34	0.82
Female	0.71	0.45	1.13
Diabetes				0.18
No	0.51	0.33	0.76
Yes	0.81	0.49	1.35
Baseline eGFR				0.47
≥ 60 mL/min	0.67	0.45	0.99
< 60 mL/min	0.50	0.29	0.88
Previous fracture				0.14
No	0.56	0.39	0.80
Yes	0.93	0.45	1.90